Search - tctmd.com

Displaying 361 - 372 of 372

Sort: Relevancy | Date

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

New CHAMPION Data Show Significant Improvement in Survival Rates for Heart Failure Patients with Reduced Ejection Fraction

March 15, 2015

Presentation TCT 2014

Decompressing the Left Atrium: V-Wave Interatrial Shunt Therapy for HFrEF

Presenter: Daniel Burkhoff, Mark Goldberger, Josep Rodés-Cabau

September 16, 2014

News Industry News

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

April 22, 2013

Video

» Topical Discussion

Quick Takes: Amin Yehya on the Use of ICD Therapy for HFrEF Patients

December 17, 2024

Video

» Topical Discussion

Quick Takes: Amole Ojo on Risks of Digoxin Use in HFrEF Patients

July 8, 2024

Partner Content

Baroreflex Activation Therapy for HFrEF Patients: New Insights from the BeAT-HF Study

March 29, 2023

Video

» Topical Discussion

Baroreflex Activation Therapy for HFrEF Patients- New Insights from the BeAT-HF Study

March 28, 2023

Video

» Live Case

Case-based Heart Failure- TAVR in Patients w Heart Failure and HFrEF

June 17, 2022

Video

TVT 2019: V-Wave for HFrEF and HFpEF

June 15, 2019

Video

TVT 2019: Transcatheter Subannular Remodeling for HFrEF: Early ANCORA Experiences

June 15, 2019

Advertisement

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

New CHAMPION Data Show Significant Improvement in Survival Rates for Heart Failure Patients with Reduced Ejection Fraction

Decompressing the Left Atrium: V-Wave Interatrial Shunt Therapy for HFrEF

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

Quick Takes: Amin Yehya on the Use of ICD Therapy for HFrEF Patients

Quick Takes: Amole Ojo on Risks of Digoxin Use in HFrEF Patients

Baroreflex Activation Therapy for HFrEF Patients: New Insights from the BeAT-HF Study

Baroreflex Activation Therapy for HFrEF Patients- New Insights from the BeAT-HF Study

Case-based Heart Failure- TAVR in Patients w Heart Failure and HFrEF

TVT 2019: V-Wave for HFrEF and HFpEF

TVT 2019: Transcatheter Subannular Remodeling for HFrEF: Early ANCORA Experiences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content